George Clinical Selected as CRO for Hummingbird Bioscience’s Phase 1 Oncology Trials in Australia
SYDNEY, May 04, 2023 (GLOBE NEWSWIRE) — George Clinical announces that the company has initiated preparations in Australia for two oncology Phase 1b trials that will examine a Hummingbird Bioscience precision therapy program targeting HER3, a potent driver of tumor